TRIAZOLINES .21. PREFORMULATION DEGRADATION KINETICS AND CHEMICAL-STABILITY OF A NOVEL TRIAZOLINE ANTICONVULSANT

被引:6
作者
HAMELIJNCK, MAF
STEVENSON, PJ
KADABA, PK
DAMANI, LA
机构
[1] KINGS COLL LONDON,CHELSEA DEPT PHARM,LONDON SW3 6LX,ENGLAND
[2] UNIV KENTUCKY,ALBERT B CHANDLER MED CTR,COLL PHARM,LEXINGTON,KY 40536
关键词
D O I
10.1002/jps.2600810421
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effect of pH, temperature, and two buffer species (citric acid-phosphate and bicarbonate-carbonate) on the stability of 1-(4-chlorophenyl)-5-(4-pyridyl)-DELTA(2)-1,2,3-triazoline (ADD17014; 1), a novel triazoline anticonvulsant, was determined by HPLC. One of the main degradation products of 1 at pH 7.0 was isolated by TLC and identified as the aziridine derivative by MS. Investigations were carried out over a range of pH (2.2-10.7) and buffer concentration [ionic strength (mu), 0.25-4.18] at 23-degrees-C. The degradation followed buffer-catalyzed, pseudo-first-order kinetics and was accelerated by a decrease in pH and an increase in temperature. The activation energy for the degradation in citric acid-phosphate buffer (pH 7.0 and constant ionic strength-mu at 0.54) was 12.5 kcal/mol. General acid catalysis was observed at pH 7.0 in citric acid-phosphate buffer. The salt effect on the degradation obeyed the modified Debye-Huckel equation well; however, the observed charge product (Z(A)Z(B)) value (2.69) deviated highly from the theoretical value (1.0), perhaps because of the high mu values (0.25-4.18) of the solutions used. The stability data will be useful in preformulation studies in the development of a stable, oral dosage form of 1.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 10 条
[1]   KINETIC SALT EFFECT IN PHARMACEUTICAL INVESTIGATIONS [J].
CARSTENSEN, JT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (08) :1140-+
[2]  
KADABA P K, 1990, Drugs of the Future, V15, P1013
[3]  
KADABA PK, 1984, ADV HETEROCYCL CHEM, V37, P217, DOI 10.1016/S0065-2725(08)60243-3
[4]   TRIAZOLINES .8. ACTION OF DIAZOALKANES ON HETEROCYCLIC SUBSTITUTED SCHIFF-BASES [J].
KADABA, PK .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1975, 12 (01) :143-146
[6]   TRIAZOLINES .15. ANTICONVULSANT PROFILE OF ADD-17014, A POTENTIALLY UNIQUE 1,2,3-TRIAZOLINE ANTIEPILEPTIC DRUG, IN MICE AND RATS [J].
KADABA, PK ;
SLEVIN, JT .
EPILEPSIA, 1988, 29 (03) :330-337
[8]  
LAITINEN HA, 1960, CHEMICAL ANALYSIS, P35
[9]   TRIAZOLINES .22. CHROMATOGRAPHY OF 1-PHENYL-5-(4-PYRIDYL)-DELTA-2-1,2,3-TRIAZOLINES AND RELATED 1,2,3-TRIAZOLES, A NEW CLASS OF ANTICONVULSANT AGENTS [J].
STEVENSON, PJ ;
HAUKSDOTTIR, R ;
KADABA, PK ;
DAMANI, LA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 533 :248-254
[10]   TRIAZOLINES .23. HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY IN RAT-BLOOD FOR A NOVEL TRIAZOLINE ANTICONVULSANT (ADD17014) [J].
STEVENSON, PJ ;
HAMELIJNCK, MAF ;
KADABA, PK ;
DAMANI, LA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 563 (02) :419-426